• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchIRulya Therapeutics
    Picture of IRulya Therapeutics logo

    IRLA — IRulya Therapeutics News Story

    $32.830.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $355.93m
    • Enterprise Value
      $383.76m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IRLA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IRLA Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of IRulya Therapeutics logoIRulya Therapeutics
    13/04/2026 14:00
    NASDAQ RESUMED  QNCX.O  AT 09:00 AM
    

    Recent news on IRulya Therapeutics

    See all news
    • Brief: Quince Therapeutics - Changes Name To Irulya Therapeutics

      09/10/2026 13:12
    • Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026

      09/10/2026 13:10
    • Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary

      14/08/2026 15:11
    • Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update

      14/08/2026 13:39
    • Quince Therapeutics Q2 net loss widens on acquisition charges

      14/08/2026 13:18

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.